TrialLancet (London, England)2021

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Mehreen S Datoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.